XML 35 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Segmentation of key figures (Tables)
 6 Months Ended
Jun. 30, 2020
Operating Segments [Abstract]  
Disclosure of operating segments
Segmentation - Consolidated income statements
Three months ended June 30, 2020 and 2019
 
Surgical
 
Vision Care
 
Company
 
Three months ended June 30
 
Three months ended June 30
 
Three months ended June 30
($ millions)
2020

2019


2020

2019


2020

2019

Net sales to third parties
602

1,051

 
596

812

 
1,198

1,863

Other revenues
—

—

 
16

40

 
16

40

Net sales and other revenue
602

1,051

 
612

852

 
1,214

1,903

Segment contribution
(28
)
235

 
22

143

 
(6
)
378

Amortization of intangible assets
 
 
 
 
 
 
(273
)
(270
)
Impairment charges on intangible assets
 
 
 
 
 
 
(41
)
—

General & administration (corporate)
 
 
 
 
 
 
(62
)
(54
)
Separation costs
 
 
 
 
 
 
(62
)
(78
)
Transformation costs
 
 
 
 
 
 
(13
)
(5
)
Fair value adjustments of contingent consideration liabilities
 
 
 
 
 
 
(4
)
3

Other
 
 
 
 
 
 
(5
)
(27
)
Operating (loss)
 
 
 
 
 
 
(466
)
(53
)
Interest expense
 
 
 
 
 
 
(30
)
(35
)
Other financial income & expense
 
 
 
 
 
 
(6
)
(8
)
(Loss) before taxes
 
 
 
 
 
 
(502
)
(96
)

Six months ended June 30, 2020 and 2019

 
Surgical
 
Vision Care
 
Company
 
Six months ended June 30
 
Six months ended June 30
 
Six months ended June 30
($ millions)
2020

2019

 
2020

2019

 
2020

2019

Net sales to third parties
1,586

2,051

 
1,434

1,589

 
3,020

3,640

Other revenues
—

—

 
35

87

 
35

87

Net sales and other revenues
1,586

2,051

 
1,469

1,676

 
3,055

3,727

Segment contribution
180

463

 
188

301

 
368

764

Amortization of intangible assets
 
 
 
 
 
 
(545
)
(536
)
Impairment charges on intangible assets
 
 
 
 
 
 
(57
)
—

General & administration (corporate)
 
 
 
 
 
 
(115
)
(102
)
Separation costs
 
 
 
 
 
 
(133
)
(78
)
Spin readiness costs
 
 
 
 
 
 
—

(72
)
Transformation costs
 
 
 
 
 
 
(20
)
(5
)
Fair value adjustments of contingent consideration liabilities
 
 
 
 
 
 
40

13

Other
 
 
 
 
 
 
(32
)
(85
)
Operating (loss)
 
 
 
 
 
 
(494
)
(101
)
Interest expense
 
 
 
 
 
 
(61
)
(44
)
Other financial income & expense
 
 
 
 
 
 
(16
)
(16
)
(Loss) before taxes
 
 
 
 
 
 
(571
)
(161
)
Disclosure of products and services
Net sales by segment
 
Three months ended June 30
 
Six months ended June 30
($ millions)
2020

2019

 
2020

2019

Surgical


 
 
 
Implantables
176

300

 
486

585

Consumables
320

588

 
839

1,139

Equipment/other
106

163

 
261

327

Total Surgical
602

1,051

 
1,586

2,051

Vision Care


 
 
 
Contact lenses
329

493

 
831

991

Ocular health
267

319

 
603

598

Total Vision Care
596

812

 
1,434

1,589

Net sales to third parties
1,198

1,863

 
3,020

3,640
Disclosure of geographical areas
Net sales by region(1)
 
Three months ended June 30
 
Six months ended June 30
($ millions unless indicated otherwise)
2020
 
2019
 
 
2020
 
2019
 
United States
493

41
%
779

42
%
 
1,285

43
%
1,516

42
%
International
705

59
%
1,084

58
%
 
1,735

57
%
2,124

58
%
Net sales to third parties
1,198

100
%
1,863

100
%
 
3,020

100
%
3,640

100
%
(1) Net sales to third parties by location of third-party customer.